Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation

Area of Science:

• Cell Biology
• Bone Biology
• Developmental Biology

Background:

• Mammalian sterile 20-like kinase 2 (Mst2) is a key component of the Hippo pathway, regulating cell growth and apoptosis.
• The specific roles of Mst2 in osteoclast and osteoblast development remain largely uncharacterized.

Purpose of the Study:

• To investigate the function of Mst2 in osteoclast and osteoblast differentiation and its impact on bone homeostasis.
• To elucidate the molecular mechanisms by which Mst2 influences bone metabolism.

Main Methods:

• Mice with Mst2 deficiency were analyzed using micro-computed tomography (µCT) and histomorphometry.
• In vitro studies involved osteoclast and osteoblast precursors to assess differentiation and gene expression.
• The NF-κB pathway activation was examined in Mst2-deficient cells.

Main Results:

• Mst2-deficient mice displayed osteoporotic phenotypes, characterized by increased osteoclasts and reduced osteoblasts.
• Mst2 deficiency enhanced osteoclastogenesis and specific gene expression (Nfatc1, Acp5, Oscar) upon RANKL stimulation.
• Mst2 deficiency impaired osteoblast differentiation and function, downregulating key genes (Runx2, Alpl, Ibsp, Bglap).
• NF-κB pathway activation was observed in Mst2-deficient osteoclast and osteoblast precursors.

Conclusions:

• Mst2 plays a critical role in maintaining bone homeostasis.
• Mst2 acts as a reciprocal regulator of osteoclast and osteoblast differentiation.
• The NF-κB pathway is implicated in Mst2's regulation of bone metabolism.